<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Low serum adiponectin (ADPN) has been associated with increased risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In type 1 diabetic patients, the relationship between ADPN and the presence of vascular complications is largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We investigated the relationship between serum ADPN and the presence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, divided into matched groups with normoalbuminuria and no <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (n=67), simplex <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (n=106) or proliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (n=19), and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> with simplex (n=62) or proliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (n=137) </plain></SENT>
<SENT sid="3" pm="."><plain>Healthy control subjects (n=25) were included </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Serum ADPN was increased in subjects with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with control subjects (p&lt;0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>Further, serum ADPN was higher in patients with than in those without <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (p&lt;0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>It was also higher in normoalbuminuric patients with than in those without proliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (p&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>These differences remained significant after adjustment for known risk factors (p&lt;0.03) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was also associated with elevated ADPN levels (p&lt;0.05), but this difference became insignificant after risk factor adjustment </plain></SENT>
<SENT sid="9" pm="."><plain>The most important predictor of serum ADPN was sex (r2=19%) in normoalbuminuric patients and GFR in patients with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (r2=18%) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION/INTERPRETATION: Patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and microvascular complications have higher serum levels of ADPN than patients without complications </plain></SENT>
<SENT sid="11" pm="."><plain>It remains to be clarified whether elevated levels of ADPN are pathogenically related to the development of microvascular complications or represent a beneficial counter-regulatory response </plain></SENT>
</text></document>